NDC 49702-258

Triumeq PD

Abacavir Sulfate, Dolutegravir Sodium, Lamivudine

Triumeq PD is a Kit in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is .

Product ID49702-258_7270d03e-4afd-4242-a4bf-ff14f79fc16c
NDC49702-258
Product TypeHuman Prescription Drug
Proprietary NameTriumeq PD
Generic NameAbacavir Sulfate, Dolutegravir Sodium, Lamivudine
Dosage FormKit
Marketing Start Date2022-03-30
Marketing CategoryNDA /
Application NumberNDA215413
Labeler NameViiV Healthcare Company
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 49702-258-37

1 KIT in 1 CARTON (49702-258-37) * 90 TABLET, FILM COATED in 1 BOTTLE (49702-272-59)
Marketing Start Date2022-03-30
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Triumeq PD" or generic name "Abacavir Sulfate, Dolutegravir Sodium, Lamivudine"

NDCBrand NameGeneric Name
49702-258Triumeq PDabacavir sulfate, dolutegravir sodium, lamivudine
49702-231Triumeqabacavir sulfate, dolutegravir sodium, lamivudine
50090-1606Triumeqabacavir sulfate, dolutegravir sodium, lamivudine

Trademark Results [Triumeq PD]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TRIUMEQ PD
TRIUMEQ PD
90032640 not registered Live/Pending
ViiV Healthcare Company
2020-07-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.